AmmarSarwarMD

Interventional Neuroradiology, Vascular & Interventional Radiology

Physician

Dr. Sarwar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Ammar Sarwar is a radiologist in Boston, MA and is affiliated with Beth Israel Deaconess Medical Center. He received his medical degree from King Edward Medical University and has been in practice 12 years. He specializes in interventional neuroradiology and vascular & interventional radiology and is experienced in endovascular coiling. He has more than 80 publications and over 500 citings.

Beth Israel Deaconess Medical CenterFellowship, Vascular and Interventional Radiology, 2013 - 2014
Beth Israel Deaconess Medical CenterResidency, Radiology-Diagnostic, 2009 - 2013
MetroWest Medical CenterInternship, Transitional Year, 2008 - 2009
King Edward Medical UniversityClass of 2005

PubMed

Combining Radioembolization and Immune Checkpoint Inhibitors for the Treatment of Hepatocellular Carcinoma: The Quest for Synergy.
Christopher D Malone, Suryansh Bajaj, Aiwu He, Kabir Mody, Ryan Hickey
Journal of Vascular and Interventional Radiology. 2024-11-23
Safety and Efficacy of Early Primary Stent Placement for Hepatic Artery Stenosis in Liver Transplant Recipients.
Vijay Ramalingam, Sheikh Muhammad Usman Shami, Jeffrey Weinstein, David Lee, Michael Curry
Journal of Vascular and Interventional Radiology. 2024-11-23
Thirty-Day Healthcare Encounters after Elective Uterine Artery Embolization for Fibroids with and without Superior Hypogastric Nerve Block.
Nicole H Kim, Ammar Sarwar, Muhammad Mohid Tahir, Razan Ali, Sarah E Schroeppel DeBacker
Journal of Vascular and Interventional Radiology. 2024-10-24

ABK Biomedical Announces FDA IDE Stage 2 Approval for Route90, a Prospective, Multi-Center, Pivotal Study of Eye90 Microspheres® in Unresectable Hepatocellular CancerNovember 19th, 2024
IR Proves Strong on Practicality, Profitability—but Some Cost-Inclusive Metrics Remain to Be ShownMarch 23rd, 2023
Using Electronic Data Collection Platforms to Assess Complementary and Integrative Health Patient-Reported Outcomes: Feasibility ProjectJune 26th, 2020
Join now to see all